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Low fertility may be a significant
determinant of ovarian cancer worldwide:
an ecological analysis of cross- sectional
data from 182 countries
Wenpeng You1* , Ian Symonds1 and Maciej Henneberg1,2
Abstract
Background: Ageing, socioeconomic level, obesity, fertility, relaxed natural selection and urbanization have been
postulated as the risk factors of ovarian cancer (OC56). We sought to identify which factor plays the most significant
role in predicting OC56 incidence rate worldwide.
Methods: Bivariate correlation analysis was performed to assess the relationships between country-specific estimates
of ageing (measured by life expectancy), GDP PPP (Purchasing power parity), obesity prevalence, fertility (indexed by
the crude birth rate), opportunity for natural selection (Ibs) and urbanization. Partial correlation was used to compare
contribution of different variables. Fisher A-to-Z was used to compare the correlation coefficients. Multiple linear
regression (Enter and Stepwise) was conducted to identify significant determinants of OC56 incidence. ANOVA with
post hoc Bonferroni analysis was performed to compare differences between the means of OC56 incidence rate and
residuals of OC56 standardised on fertility and GDP respectively between the six WHO regions.
Results: Bivariate analyses revealed that OC56 was significantly and strongly correlated to ageing, GDP, obesity, low
fertility, Ibs and urbanization. However, partial correlation analysis identified that fertility and ageing were the only
variables that had a significant correlation to OC56 incidence when the other five variables were kept statistically
constant. Fisher A-to-Z revealed that OC56 had a significantly stronger correlation to low fertility than to ageing.
Stepwise linear regression analysis only identified fertility as the significant predictor of OC56. ANOVA showed that,
between the six WHO regions, multiple mean differences of OC56 incidence were significant, but all disappeared when
the contributing effect of fertility on OC56 incidence rate was removed.
Conclusions: Low fertility may be the most significant determining predictor of OC56 incidence worldwide.
Keywords: Ovarian cancer, Low fertility, Oxytocin, Significant predictor, Family well-being
Background
Ovarian Cancer (OC56, abbreviated as per the International
Classification of Diseases published by the WHO) [1] ranks
among the top ten most commonly diagnosed cancers and
top five deadliest cancers in most countries [2, 3]. In 2015,
OC56 was present in 1.2 million women and resulted in
161,100 deaths worldwide [4] . In the twenty-first century, a
woman’s overall lifetime risk of developing OC56 is around
1.6% [2, 5, 6], and her chance of dying of the disease is 1 in
100 [2, 6].
Although OC56 has been known to medical scientists
for over 150 years [7], the aetiology of this lethal disease
is not well understood. Most research on the aetiology
of OC56 has focused on genetic and environmental car-
cinogenic factors, such as talc, pesticides, red meat and
alcohol in diet, smoking, and herbicides. However, to date,
none of these factors has been consistently shown to be a
major risk factor for the development of OC56 [8]. Alter-
native hypotheses for the aetiology of the disease have also
been suggested. Several studies have suggested that,
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obese women (those with a body mass index of at least
30 kg/m2) may have a greater risk of developing OC56
because of their elevated levels of circulating estrogen
[9–11]. An accumulation of somatic mutations has
been suggested as the mechanism for the higher inci-
dence of the disease in women over the age of 45 [9].
Urbanization may have improved public hygiene, sani-
tation and access to health care for women [12], but it
has been associated with public health issues, including
OC56 [13] due to the changes in occupational, dietary
and exercise patterns [6, 12, 14, 15].
Natural selection, as one of the key mechanisms of evo-
lution, differentiates phenotypes’ survival and/or fertility
that reflect genetic differences. The Biological State
Index (Ibs) has been constructed to measure the opportun-
ity for natural selection through differential mortality at
the population level. The Ibs calculation combines life
table function dx (number of deaths at age x) with the
age-specific completed relative fertility rate sx (fraction of
total fertility rate to a woman up to age x): Ibs = 1 – Σdxsx
[16–21]. Ibs can be used as a way of measuring the oppor-
tunity for an individual born into a given population to pass
on its genes to the next generation [17, 19, 22–24]. Ibs
has been postulated to reflect changes in the mutation-
selection balance as a result of the effect of improved
healthcare on relaxing natural selection and thus meas-
ure the magnitude of accumulation of the deleterious
genes [16], including those responsible for cancers such
as OC56 [17], type 1 diabetes [18] and obesity [18, 19]
in human populations.
The association between low fertility and OC56 risk has
been well described and it has been postulated that this
risk increases in women who have ovulated less over their
lifetime either through infertility or administering the com-
bined birth controls, such as contraceptive pills [6, 25–32].
To the best of our knowledge, despite that low fertility
is a well-established risk factor for OC56, no research
has compared the contributing effects of fertility to
OC56 with other OC56 risk factors, such as ageing, Ibs
(index of magnitude of OC56 genes accumulation in
human populations), obesity and socioeconomic factors
(GDP and urbanization).
There is significant variation in the incidence of OC56
between different geographic regions globally [2, 3, 33–35].
This phenomenon has also been observed in different pop-
ulations [6, 13] within the same countries [36, 37]. A num-
ber of publications suggest that the disparity between
regions and populations is related to socioeconomic level.
In this study, empirical macro-level data have been used
to test the hypothesis that fertility (measured by the crude
birth rate) is the principal determinant of developing
OC56, and that it is fertility, instead of GDP, that is
most important factor in shaping the regional variation
of OC56 incidence rate.
Methods
Data sources
The following country specific data published by the agen-
cies of the United Nations were analysed for this study.
1. The GLOBOCAN 2012 estimates of incidence rate
of female OC56 [34].
GLOBOCAN provides contemporary population level
estimates by cancer site and sex [2]. This project is con-
ducted by the WHO research agency, the International
Agency for Research on Cancer (IARC).
OC56 incidence rate is expressed as the number per
100,000 females who were diagnosed with OC56 in 2012.
The age-standardized OC56 incidence rate was selected in
the interest of the data comparability between countries.
2. The World Bank published data on crude birth rate,
per capita GDP PPP and urbanization [38]
Crude birth rate (CBR) indicates the number of live
births occurring during the year, per 1000 population esti-
mated at midyear. CBR was used to index the fertility in
this study over a 20 year period (1992) to reflect long ex-
posure with delayed presentation of OC56. Terms “birth
rate” and “fertility” are interchangeable in this paper.
Socio-economic level has been associated with OC56
risk [2, 34, 39, 40]. We chose per capita GDP purchasing
power rate (GDP PPP in 2012 international $) because it
takes into account the relative cost of local goods, ser-
vices and inflation rates of the country.
Urbanization has been postulated as a major OC56
predictor [41, 42] because it represents the major demo-
graphic shift entailing lifestyle changes [12, 43, 44].
Urbanization is expressed with the country-specific per-
centage of total population living in urban areas in 2012.
3. The United Nations statistics division estimates of
the life expectancy [45]
Country-specific life expectancy, which reflects ageing,
has been well established to be correlated with OC56 in-
cidence [46, 47]. Therefore, we selected life expectancy
of older people (e65, 2005–2010) [45] to index the ageing
process at population level.
4. The magnitude of OC56 gene accumulation in a
population indexed with the biological state index (Ibs)
The country specific Ibs was downloaded from the previ-
ous publication [19]. It has been postulated that reduced
natural selection (measured by Ibs) may have allowed ac-
cumulation of deleterious genes of non-communicable
diseases [17–19], such as OC56 [17].
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5. The WHO Global Health Observatory (GHO) data
on obesity prevalence
Obese females may be at greater risk of developing
OC56 than those who are not obese [48]. The country-
specific percentage of the females aged 18+ with a BMI ≥
30 kg/m2 in 2010 was extracted from the GHO data
repository [49].
Data selection
Country specific OC56 incidence rates, ageing, fertility,
GDP, Ibs, obesity and urbanization were collated for all
countries where data were available. We extracted OC56
incidence rates for 182 countries and then the other var-
iables were matched individually with OC56.
Each country was treated as an individual study subject
in the data analysis. Not all the countries (subjects) had
information for all the variables.
The relevant United Nations agencies offer free online
access to data required for the analyses in this study. No
ethics approval was required as there were no individual
patients involved in the study.
Data multicollinearity check
In order to avoid the inter-correlation between predictor
variables, the multicollinearity statistics were calculated
to test the correlations among the variables. Each vari-
able was alternated as the dependent variable, and all
the others were considered as the predictor variables in
our analysis with the regression model. It was found that
the collinearities between variables were not significant
since only the tolerance of less than 0.20 and a VIF of
more than 5 indicates a multicollinearity problem [50].
Values in our study were more than 0.20 and less than 5
respectively. Details are provided in Additional file 1.
Data analysis
To assess the population level determinants of OC56,
the analysis proceeded in five steps.
1. Scatter plots were produced with the original data
in Microsoft Excel® to explore and visualize the
strength, shape and direction of correlations of
OC56 to fertility and GDP respectively.
2. Data were logarithmed to improve their
homoscedasticity for linear regression analyses.
Bivariate (Pearson’s r and nonparametric Spearman’s
rho) correlations were performed to evaluate the
direction and strength of the correlations between all
the variables of all the subjects and effects possible
effects of non-normality of distributions on the
strength of moment-product correlations.
3. Partial correlation analysis of Pearson’s moment-
product approach was performed. We alternated
each of the six variables (ageing, fertility, GDP, Ibs,
obesity and urbanization) as the independent
predictor when all other five variables were
included as the potential confounding factors.
Fisher’s r-to-z transformation was applied to assess
the significance level of difference between pairs of
correlation coefficients.
4. Standard multiple linear regression (enter) was
performed to describe the correlations between the
dependent variable (OC56) and the predicting
variables. In order to explore if low fertility can
partially explain why ageing, GDP, Ibs, obesity and
urbanization are correlated with OC56, the enter
multiple linear regression was performed to determine
the correlations between OC56 incidence and the
risk factors in two models: (1) when fertility was
incorporated; and (2) excluded as a predicting variable
Subsequently, standard multiple linear regression
(Stepwise) was performed to select the predicting
variable (s) which have the greatest influence on
OC56 in two versions: (1) when fertility was
incorporated and (2) excluded as a predicting variable.
5. The equations of the best fitting non-linear trendlines
displayed in the scatter plots analysis of relationships
between OC56 incidence and fertility (y = 0.006 × 2–
0.504× + 14.816, R2 = 0.485) and GDP PPP (y =
0.7167× + 0.2225, R2 = 0.2571) were used to calculate
and remove the contributing effects of GDP PPP on
OC56 incidence rate respectively by using regressions
of OC56 residuals around fertility and GDP PPP. This
allowed us to create two new dependent variables,
“Residual of OC56 standardised on fertility” and
“Residual of OC56 standardised on GDP PPP”
Means of the OC56 incidence rate, the “Residuals of
OC56 standardised on fertility” and “Residuals of OC56
standardised on GDP PPP” of all the countries were cal-
culated for mean difference comparisons.
Analysis of variance (ANOVA) was conducted to detect
the significant differences among the means of OC56 inci-
dence rate, “Residual of OC56 standardised on fertility”
and “Residual of OC56 standardised on GDP PPP”
between the six WHO regions [51]. Further post-hoc
(Bonferroni) tests were performed to identify the source
(pairs) of significant differences.
Bivariate correlations, multiple linear regression analysis
(Enter and Stepwise) and ANOVA were conducted with
SPSS v. 24. The raw data were used for calculation of mean
OC56 incidence rate and “Residual of OC56 standardised
on fertility” and “Residual of OC56 standardised on GDP
PPP”. The significance was kept at the 0.05 level, but 0.01
and 0.001 levels were also reported. Standard multiple lin-
ear regression analysis criteria were set at probability of F
to enter ≤0.05 and probability of F to remove ≥0.10.
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Results
The relationship identified in the scatterplots between
fertility and OC56 was noted to be polynomial with a
strong, but inverse (negative) correlation (R2 = 0.485,
p < 0.001, n = 179, Fig. 1).
The strong relationship between fertility and OC56
identified in the scatterplots was confirmed by the sub-
sequent nonparametric and Pearson r analyses based on
the log-transformed data.
Globally, fertility was significantly and negatively cor-
related to OC56 incidence (r = − 0.632 and rho = − 0.655,
p < 0.001 respectively in Pearson and non-parametric
analyses) (Table 1).
It is also found that ageing, GDP, Ibs, obesity and
urbanization had strong and significant correlations to
OC56 incidence in both Pearson and non-parametric
analyses respectively (Table 1).
The relationship between OC56 and each independent
variable (ageing, fertility, GDP, Ibs, obesity and urbanization)
was tested by keeping the other five variables statistically
constant in partial correlation analysis. Fertility was the only
predictor showing a substantial significant correlation
(r = − 0.448, p < 0.001) with OC56 independent of the
other five variables (Table 2). Ageing showed significant,
but weak correlation to OC56 (r = − 0.178, p < 0.05). The
Fisher r-to-z transformation revealed that OC56 was in
significant stronger correlation with fertility than with age-
ing (z = 2.68, p < 0.01). GDP, Ibs, obesity and urbanization
showed significant correlation to OC56 in the bivariate
correlation analyses respectively. However, none of
Fig. 1 The relationship between fertility and ovarian cancer incidence rate
Table 1 Pearson r (above the diagonal) and nonparametric “rho” (below the diagonal) correlation between all variables
OC56 Ageing Fertility GDP Ibs Obesity Urbanization
OC56 1 0.394*** −0.632*** 0.507*** 0.455*** 0.189* 0.280***
Ageing 0.428*** 1 −0.737*** 0.748*** 0.766*** 0.322*** 0.570***
Fertility −0.655*** − 0.769*** 1 −0.772*** − 0.712*** − 0.338*** − 0.557***
GDP PPP 0.531*** 0.759*** −0.813*** 1 0.742** 0.485*** 0.713***
Ibs 0.602
*** 0.849*** −0.883*** 0.858*** 1 0.457*** 0.551***
Obesity 0.169* 0.350*** − 0.377*** 0.453*** 0.409*** 1 0.484***
Urbanization 0.345*** 0.657*** −0.628*** 0.781*** 0.711*** 0.506*** 1
The table shows the bivariate correlation between all the variables. *** p < 0.001; Country number: 167–182
Ovarian cancer (OC56) incidence rate is from the International Agency for Research on Cancer. Birth rate indexing fertility, GDP PPP and urbanization are from the
World Bank. Ageing expressed as life expectancy (e65) is from the United Nations. Obesity prevalence is from the World Health Organization
Biological State Index (Ibs) was downloaded from previous publications, which were calculated with the data of the world fertility form the UN Population Council
and the WHO life tables
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these variables showed a significant correlation with OC56
independent of the other five predictors. This indicates
that fertility is the only significant predictor of OC56
independent of the secondary association between OC56
incidence and Ibs (magnitude of OC56 accumulation) and
environmental factors (ageing, fertility, GDP, obesity and
urbanization).
Standard multiple linear regression (enter) analysis was
applied to predict OC56 incidence when ageing, fertility,
GDP, obesity and urbanization were included as the inde-
pendent predicting variables.
When fertility was excluded as one of the independent
variables, GDP PPP (β= 0.471, p < 0.001) and Ibs (β= 0.250,
p < 0.05) were the two significant variables related to OC56
incidence. However, when fertility was included as an inde-
pendent predictor, only the correlation between fertility and
OC56 incidence was strong and significant. None of the
other five predictors showed strong and significant correl-
ation to OC56 (Table 3). Similarly, in a stepwise linear re-
gression model, when fertility was not included as one of the
independent predictors, GDP and Ibs were selected as the
variables having the greatest influence on the development of
OC56. However, when fertility was included together with
the other five independent variables, only fertility was se-
lected as the most influential predictor of OC56 with the R2
increase from 0.278 to 0.434. This suggested that GDP and
Ibs did not appear to account for the major part of the impact
on OC56 incidence. This finding supports our previous sug-
gestion that fertility is the significant predictor of OC56 inci-
dence in partial correlation analysis.
Table 4 showed that the mean OC56 incidence rate
was lowest in Africa (4.19) and highest in Europe (8.70).
The means of OC56 in the other four regions were 5.89
(Americas), 5.19 (Eastern Mediterranean), 5.90 (South
East Asia) and 6.63 (Western Pacific). A post hoc Bonfer-
roni analysis conducted on the multiple comparisons of
means revealed that there were a number of significant
differences in mean OC56 incidence rates between differ-
ent WHO regions (Table 4). Mean of OC56 incidence in
Europe was significantly greater than in Africa, Americas,
East Mediterranean, South East Asia and West Pacific.
Mean of OC56 in Americas was significantly greater than
in Africa. The regions with greater means of fertility had
lower means of OC56 incidence rates (r = 0.985, p < 0.001,
n = 6).
A subsequent ANOVA with post hoc Bonferroni proced-
ure performed on the means of “Residual of OC56 standar-
dised on fertility” in different WHO regions showed there
was no significant difference among and between re-
gions (Table 4). Whilst the same procedure was performed
on the means of “Residual of OC56 standardised on GDP
PPP”, the developed region, Europe still had the significantly
higher “Residual of OC56 standardised on GDP PPP” than
Africa, Americas and East Mediterranean (Table 4). The re-
sults from the post hoc Bonferroni tests conducted on com-
parisons between the WHO regions suggested that regional
variations of OC56 incidence may only reach statistically sig-
nificant levels if the contributing effect of their respective
Table 2 Comparison of partial correlation coefficients between ovarian cancer incidence and each variable when the other five
variables are controlled for
Variables Fertility Ageing GDP Ibs Obesity Urbanization
r P Df R p df r p df r p df r p df r p df
Fertility −0.448 < 0.001 160 – – – – – – – – – – – – – – –
Ageing – – – −0.178 0.023 160 – – – – – – – – – – – –
GDP – – – – – – 0.148 0.060 160 – – – – – – – – –
Ibs – – – – – – – – – 0.079 0.315 160 – – – – – –
Obesity – – – – – – – – – – – – −0.048 0.544 160 – – –
Urbanization – – – – – – – – – – – – – – – −0.131 0.095 160
The table shows partial correlations between Ovarian cancer (OC56) incidence between each variable while the other four variables are controlled for. - Controlled variable
Ovarian cancer (OC56) incidence rate is from the International Agency for Research on Cancer. Fertility indexed by birth rate, GDP PPP and urbanization are from
the World Bank. Ageing expressed as life expectancy (e65) is from the United Nations. Obesity prevalence is from the World Health Organization
Biological State Index (Ibs) was downloaded from previous publications, which were calculated with the data of the world fertility form the UN Population Council
and the WHO life tables
Table 3 Independent predictors of ovarian cancer incidence
rate based on multiple linear regression modelling (Enter)
Variable β Std. Error Sig. β Std. Error Sig.
Fertility – – – −0.694 0.111 < 0.001
Ageing −0.037 0.341 0.752 −0.207 0.309 0.052
GDP 0.471 0.055 < 0.001 0.163 0.052 0.174
Ibs 0.250 0.658 0.032 0.100 0.589 0.342
Overweight −0.056 0.069 0.496 − 0.020 0.060 0.778
Urbanization −0.122 0.105 0.211 −0.125 0.092 0.146
The table describes the multiple linear regression analysis (Enter) results
including and excluding fertility as a predictor of breast cancer. df = 164; −
excluded variable
Ovarian cancer (OC56) incidence rate is from the International Agency for
Research on Cancer. Fertility indexed by birth rate, GDP PPP and urbanization
are from the World Bank. Ageing expressed as life expectancy (e65) is from the
United Nations. Obesity prevalence is from the World Health Organization
Biological State Index (Ibs) was downloaded from previous publications, which
were calculated with the data of the world fertility form the UN Population
Council and the WHO life tables
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fertility was included. In other words, except for fertility, the
total contribution of the other OC56 risk factors to OC56
incidence may not be sufficient for the difference in mean
rates to reach significance level. This result was supported
by the findings identified in our previous partial correlation
(Table 2) and multiple linear regression analyses (Table 3)
that fertility is the critical risk factor for OC56.
Discussion
The worldwide secular trend of increased OC56 incidence
may have multiple etiologies, which may act through mul-
tiple mechanisms at different magnitudes. By examining
the correlations of OC56 with low fertility, ageing, GDP,
Ibs, obesity and urbanization respectively, this study has
shown that only fertility and aging were correlated with
Table 4 Comparison of mean differences of fertility, residuals of ovarian cancer (OC56) standardised on fertility and GDP PPP
respectively between WHO regions
OC56 incidence rate Residual of OC56 standardised on fertility Residual of OC56 standardised on GDP
I
n
Mean
J Mean difference (I-J) I
n
Mean
J Mean difference (I-J) I
n
Mean
J Mean difference (I-J)
AF
n = 46
Mean = 4.19
AM −1.70* AF
n = 45
Mean = − 0.29
AM − 0.16 AF
n = 44
Mean = − 0.15
AM −0.03
EM −0.99 EM −0.29 EM 1.03
EU −4.50*** EU −0.30 EU −2.15***
SEA −1.71 SEA −0.67 SEA −1.02
WP −2.44** WP −0.81 WP −0.98
AM,
n = 31
Mean = 5.89
AF 1.69* AM
n = 31
Mean = −0.13
AF 0.16 AM
n = 29
Mean = −0.12
AF 0.03
EM 0.70 EM −0.13 EM 1.06
EU −2.81*** EU −0.15 EU −2.12**
SEA −0.01 SEA −0.52 SEA −0.99
WP −0.74 WP −0.65 WP −0.95
EM
n = 22
Mean = 5.19
AF 0.99 EM
n = 21
Mean = 0.001
AF 0.29 EM
n = 18
Mean = −1.18
AF −1.03
AM −0.70 AM 0.13 AM −1.06
EU −3.51*** EU −0.01 EU −3.18***
SEA −0.71 SEA −0.38 SEA −2.05
WP −1.45 WP −0.52 WP −2.01
EU
n = 50
Mean = 8.70
AF 4.50*** EU
n = 49
Mean = 0.14
AF 0.30 EU
n = 50
Mean = 2.00
AF 2.15***
AM 2.81*** AM 0.15 AM 2.12**
EM 3.51*** EM 0.01 EM 3.18***
SEA 2.80* SEA −0.37 SEA 1.13
WP 2.06* WP −0.50 WP 1.17
SEA
n = 11
Mean = 5.90
AF 1.71 SEA
n = 11
Mean = 0.38
AF 0.67 SEA
n = 10
Mean = 0.87
AF 1.02
AM 0.01 AM 0.52 AM 0.99
EM 0.71 EM 0.38 EM 2.05
EU −2.80* EU 0.37 EU −1.13
WP −0.73 WP −0.13 WP 0.04
WP
n = 22
Mean = 6.63
AF 2.44** WP
n = 21
Mean = −0.01
AF 0.81 WP
n = 19
Mean = 0.83
AF 0.98
AM 0.74 AM 0.65 AM 0.95
EM 1.45 EM 0.52 EM 2.01
EU −2.06* EU 0.50 EU −1.17
SEA 0.73 SEA 0.13 SEA −0.04
The mean difference comparison results conducted with One-way ANOVA Post hoc Bonferroni are reported. *p < 0.05, **p < 0.01, ***p < 0.001
Ovarian cancer (OC56) incidence rate is from the International Agency for Research on Cancer. Fertility indexed by birth rate, GDP PPP and urbanization are from
the World Bank. Ageing expressed as life expectancy (e65) is from the United Nations. Obesity prevalence is from the World Health Organization
Biological State Index (Ibs) was downloaded from previous publications, which were calculated with the data of the world fertility form the UN Population Council
and the WHO life tables
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the OC56 incidence significantly, although the latter was
not as strongly. Statistically, this may suggest that low fer-
tility was the most significant risk factor for OC56 when
compared to ageing, GDP, Ibs, obesity and urbanization.
This finding is in agreement with three studies conducted
by Hankinson et al. [32], Vachon et al. [31] and Cramer et
al. [52] respectively which concluded that fertility is a sig-
nificantly greater predictor of OC56 risk than other com-
monly used epidemiological variables.
The relationship between female reproductive per-
formance and gynecological cancers has been known for
over 300 years [30, 53]. Previous studies in multiple dif-
ferent populations have shown that nulliparous women
have a 30–60% greater risk than parous women [52, 54].
Studies also reported that each additional full-term preg-
nancy lowers OC56 risk by approximately 15% [54, 55].
The mechanism of the influence of childbearing on reducing
OC56 risk may be that full-term pregnancy, post-partum
period and sometimes the subsequent lactation involve ano-
vulation, suppress secretion of pituitary gonadotropins,
lower levels of oestrogen [56–59], lessen exposure of the
ovaries to chronic inflammation and mutation [60], and re-
duce proliferation of malignant transformations in the inclu-
sion cysts and clefts which are invaginated and formed in
the ovarian epithelium during ovulation [61].
Recent studies suggested that women with greater fertil-
ity may receive the protection against developing OC56
because:
1) They may produce more oxytocin [62–69] due to
positive interactions between family members,
especially those between spouses [64, 65, 70, 71].
Oxytocin may inhibit the progression of human
ovarian carcinoma cells [28, 29].
2) They may have less stress due to more positive
psychological well-being from greater family size,
reduces stress levels. This may make their
neuroendocrine and immune systems more
efficient to reduce the risk of cancer (developing
OC56) [72–75].
3) They are more likely to seek health service and
maintain a healthy lifestyle [76–79], which may
have their developing OC56 diagnosed earlier and
removed in time.
This study revealed that low fertility determines the
variation of OC56 incidence rate among the WHO re-
gions. This finding contradicts the WHO and IARC’s
statement that socioeconomic level is the determinant of
regional variation of OC56 incidence rate [2, 6, 34]. This
may suggest that the correlation between fertility and
socioeconomic status (SES) is spurious – caused by the
correlation of both variables (SES and OC56 incidence)
to the same one (fertility) [80–82].
The strength of this study is that it uses an ecological
study approach, different from hitherto used approaches,
to demonstrate that low fertility is a significant deter-
minant of OC56 risk.
We need to note several limitations of this study:
1) Each country was considered as a whole subject
for the ecological study. The country-specific data
included in this study may be different from those
collected from individual participants. Therefore,
the correlations identified from the data analysis
may not hold true for all the individuals to have
the risk in OC56 development.
2) There may be some random errors that occurred
when the United Nations and its agencies collected
and aggregated data at country level. Data from
developed countries may be more complete than
those from developing countries.
3) There are different categories of OC56, but we
could not differentiate them for the correlation
analysis due to the unavailability of such data.
Conclusion
Low fertility appears to be a significant and strong deter-
minant of OC56 risk independent of ageing, GDP, Ibs,
obesity and urbanization. These findings may be helpful
for governments, policy-makers, funders, clinicians and
researchers when determining future screening and primary
presentation strategies for the disease [32, 83, 84].
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